- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Nikki Reeves
News 17 results
Recognition
February 13, 2025
Chambers Global 2025 Recognizes King & Spalding as a Leading International Law Firm
In the News · Source: FDA Watch
Recognition
September 20, 2024
Nikki Reeves Receives Women, Influence & Power Award from Corporate Counsel Magazine
Recognition
September 19, 2024
King & Spalding Earns Multiple Rankings in LMG Life Sciences 2024 Guide
Events 31 results
Webinar
April 29, 2025
FCA Enforcement and Litigation: How Recent Decisions and Policy Announcements Signal Key Changes
Webinar
January 29, 2025
Summary of FDA’s New Final Guidance: Scientific Information on Unapproved Uses
Webinar
January 22, 2025
Year in Review for Drug and Device Advertising and Promotion
Speaking Engagement
January 6, 2025
Nikki Reeves to Speak at Inaugural Episode of FDAWatch
Insights 31 results
Client Alert
May 9, 2025
New Executive Order Promotes Domestic Production of Critical Medicines
Article · Source: Thomson Reuters Westlaw Today
April 25, 2025
Recent decisions and DOJ policy announcements signal key changes to FCA enforcement and litigation environment
Client Alert
March 11, 2025
Recent Decisions and DOJ Policy Announcements Signal Key Changes to FCA Enforcement and Litigation Environment
Client Alert
January 13, 2025
FDA Finalizes Guidance on Scientific Information on Unapproved Uses (SIUU)